P. Vertongen et al., COMPARISON BETWEEN VASOACTIVE INTESTINAL POLYPEPTIDE AND PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE LEVELS IN NEUROBLASTOMA TUMOR-TISSUES, Neuropeptides, 31(5), 1997, pp. 409-413
Vasoactive intestinal polypeptide (VIP) is reported to exert an autocr
ine control on neuroblastoma cell tumours: VIP is produced by the tumo
ur and stimulates cell differentiation. This study tested the hypothes
is that the parent peptide, the pituitary adenylate cyclase activating
polypeptide (PACAP) may have a similar role. It was found that PACAP
mRNA and PACAP were expressed in 12/12 tumours; it was also observed t
hat PACAP receptor mRNA and functional PACAP receptors were expressed
in 12/12 and 5/9 tumours, respectively. VIP mRNA and VIP were detected
in 9/12 tumours, VIP receptor mRNA was expressed in 5/12 tumours and
functional VIP receptors were never demonstrated. The tumours having t
he highest VIP levels also had the highest PACAP contents and were ass
ociated with a watery diarrhoea syndrome due to activation of intestin
al VIP receptors, As PACAP recognizes the PACAP receptors and the VIP
receptors with the same high affinity it may contribute to the syndrom
e and is a likely candidate for an autocrine control of neuroblastoma
cell growth and differentiation.